Jonathan Violin

Insider Reports History

Location
Chesterbrook, PA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Jonathan Violin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Violin:

Form 4 holding Chief Executive Officer, Director

Viridian Therapeutics, Inc.\DE

Security class
Common Stock
Shares / value
480,905
Estimated value
$10,099,005
Report date
02 Feb 2023
Price
$21.00
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

Viridian Therapeutics, Inc.\DE

Security class
Stock Option (Right to Buy)
Shares / value
239,205
Estimated value
Report date
02 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GLYCOMIMETICS INC

Security class
Stock Option (Right to Buy)
Shares / value
9,023
Estimated value
Report date
23 Jun 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Jonathan Violin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .